NovoCure (NVCR) Launches 12.5M Common Stock IPO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/3/2026
- Wall Street ends lower as Middle East tensions escalate
- Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
- Broadcom's sales and AI chip forecast comes in below expectations, shares tumble
- SpaceX sets IPO price at $135 ahead of roadshow in break with Wall Street norms
- Oil gains as Middle East hostilities flare
- Morgan Stanley lifts MU and SNDK targets, sees 2-3 years of tight memory supply
- Navitas showcases 800V power delivery board at NVIDIA MGX ecosystem event
- Inotiv files for bankruptcy with $65 million financing commitment
- Alphabet plans $80 billion equity raise to fund AI infrastructure expansion, Berkshire Hathaway to invest $10 billion
- Alphabet plans $80 billion raise for AI, backed by Buffett’s Berkshire
- After-Hours Stock Movers: AVGO, CRWD, FIVE, AI, TLYS, NTSK,
- After-Hours Stock Movers: PANW, CRWD, ZS, GTLB, ULTA
- After-Hours Stock Movers: HPE, CRDO, FULC, ABVX, MCHP
- After-Hours Stock Movers: DELL, MDB, AEO, NTAP, GAP, S, ADSK
- After-Hours Stock Movers: CRM, MRVL, SNOW, HPQ, DDOG, MDB, P, SNPS, BRZE, NCNO
NovoCure Limited (NVCR) IPO Opens Lower
October 2, 2015 10:43 AM EDTToday's IPO for NovoCure Limited (Nasdaq: NVCR) opened for trading at $20.16 after pricing 12,500,000 shares of its common stock at $22, below the $23-$24 revised IPO range. Shares last traded at $19.
J.P. Morgan Securities LLC, Deutsche Bank Securities and Evercore Group... More
NovoCure (NVCR) Trims IPO Expectations
October 1, 2015 2:10 PM EDTNovoCure Ltd. (Nasdaq: NVCR) filed an amended registration with the U.S. SEC today. The company now plans to offer 7.5 million ordinary shares and sees an offering price of $23 - $24 per share, from prior expectations of offering 12.5 million shares with an expected pricing... More
